BTK and chronic kidney disease: However, a novel mechanism behind the suppression of IMD1–53 on VC [70] has been proposed by Chang et al. In their study, IMD1–53 administration has been shown to attenuate VC, suppress osteoblast-like cell formation, and increase the expression of Klotho in the aorta of CKD rats.